A new study carried out by MSD Pharmaceuticals, a wholly-owned subsidiary of Merck and Co Inc (USA), revealed that India is home to the largest population of diabetics in the world with over 30 million people suffering from the disease.
The study claimed, “India is considered the diabetic capital in the world, with the largest population of diabetics.”
Besides, the company has also launched 'Januvia' (Sitagliptin), an approved Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes, in Kolkata on Thursday.